INOVIO PHARMACEUTICALS, INCINOVIO PHARMACEUTICALS, INCINOVIO PHARMACEUTICALS, INC

INOVIO PHARMACEUTICALS, INC

No trades
See on Supercharts

Price target

217.320.000.00%
The 6 analysts offering 1 year price forecasts for INO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to INO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


INO EPS for the last quarter is −17.54 MXN despite the estimation of −22.66 MXN. In the next quarter EPS is expected to reach −18.59 MXN. Track more of INOVIO PHARMACEUTICALS, INC financials and stay on top of what is up with the company.
In the next quarter INOVIO PHARMACEUTICALS, INC revenue is expected to reach ‪1.10 M‬ MXN. Check out INOVIO PHARMACEUTICALS, INC revenue and earnings and make informed decisions.
According to analysts, INO price target is 217.32 MXN with a max estimate of 366.73 MXN and a min estimate of 101.87 MXN. Check if this forecast comes true in a year, meanwhile watch INOVIO PHARMACEUTICALS, INC stock price chart and keep track of the current situation with INO news and stock market news.
We've gathered opinions of 6 analysts rating INO stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.